Active Pharmaceutical Ingredients (APIs) are combined with excipients (inactive substances) to make drugs. Here you will find content about the development, manufacturing, analysis and regulation of pharmaceutical APIs.
Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.
Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success
In many ways, the beginning of 2021 isn’t just one of the most welcome New Years of the modern era — it could also be a turning point between the pre-COVID and post-COVID worlds...
A 433-acre campus once owned by Bristol Myers Squibb is now being marketing as the perfect location for pharma companies looking to expand their manufacturing footprint in the...
Cadila Pharmaceuticals, one of the largest privately held pharma companies in India, shut down its API manufacturing plant in Ahmedabad after 26 employees tested positive for ...
